1. Home
  2. SUPN vs NYAX Comparison

SUPN vs NYAX Comparison

Compare SUPN & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$43.53

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Nayax Ltd.

NYAX

Nayax Ltd.

N/A

Current Price

$52.24

Market Cap

2.6B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SUPN
NYAX
Founded
2005
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
SUPN
NYAX
Price
$43.53
$52.24
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$61.60
$49.50
AVG Volume (30 Days)
581.4K
22.7K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
N/A
Revenue This Year
$22.70
$30.66
Revenue Next Year
$19.14
$21.70
P/E Ratio
N/A
$89.78
Revenue Growth
N/A
N/A
52 Week Low
$42.45
$39.17
52 Week High
$59.68
$76.86

Technical Indicators

Market Signals
Indicator
SUPN
NYAX
Relative Strength Index (RSI) 41.02 44.22
Support Level $44.09 $50.78
Resistance Level $52.33 $55.40
Average True Range (ATR) 1.30 1.24
MACD -0.29 0.86
Stochastic Oscillator 19.63 70.34

Price Performance

Historical Comparison
SUPN
NYAX

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: